Suchergebnisse - "Antisickling Agents therapeutic use"

Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice

Autoren: Camila B. Almeida Christoph Scheiermann Nicola Conran et al.

Quelle: Blood, Vol. 120, No 14 (2012) pp. 2879-2888

Schlagwörter: Male, 0301 basic medicine, Erythrocytes, Hydroxyurea/therapeutic use, Pyrazoles/pharmacology, Leukocytes/cytology/drug effects, 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors/metabolism, Anemia, Sickle Cell, Cell Communication, Erythrocytes/cytology/drug effects, Mice, 03 medical and health sciences, Vascular Diseases/chemically induced/drug therapy/metabolism, Anemia, Sickle Cell/chemically induced/drug therapy/metabolism, Antisickling Agents, Cell Adhesion, Leukocytes, Antisickling Agents/therapeutic use, Animals, Humans, Hydroxyurea, Cell Adhesion/drug effects, Leukocyte Rolling, Pyrimidines/pharmacology, Cyclic GMP, 0303 health sciences, Tumor Necrosis Factor-alpha/toxicity, 3. Good health, Mice, Inbred C57BL, Cyclic GMP/metabolism, Disease Models, Animal, 3',5'-Cyclic-AMP Phosphodiesterases, Endothelium, Vascular/cytology/drug effects/metabolism, Acute Disease, Pyrazoles, Female, Endothelium, Vascular

Dateibeschreibung: application/pdf

Zugangs-URL: https://ashpublications.org/blood/article-pdf/120/14/2879/1357145/zh804012002879.pdf
https://pubmed.ncbi.nlm.nih.gov/22833547
https://www.sciencedirect.com/science/article/pii/S000649712046344X
https://bv.fapesp.br/pt/publicacao/62110/hydroxyurea-and-a-cgmp-amplifying-agent-have-immediate-benef/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466969/
http://europepmc.org/articles/PMC3466969
https://ashpublications.org/blood/article/120/14/2879/30514/Hydroxyurea-and-a-cGMP-amplifying-agent-have
https://www.bloodjournal.org/content/bloodjournal/120/14/2879.full.pdf
https://archive-ouverte.unige.ch/unige:113715
https://archive-ouverte.unige.ch/unige:113715
https://doi.org/10.1182/blood-2012-02-409524

The Genomics of New Drugs in Sickle Cell Disease

Autoren: Makis, A. C. Hatzimichael, E. C. Stebbing, J.

Quelle: Pharmacogenomics. 7:909-917

Schlagwörter: 0301 basic medicine, Hydroxyurea/therapeutic use, Sulfasalazine/therapeutic use, Drug Resistance, Anemia, Sickle Cell/*drug therapy/*genetics/metabolism, Anemia, Sickle Cell, Poloxamer, Decitabine, Nitric Oxide, Toxicogenetics, Azacitidine/analogs & derivatives/therapeutic use, 03 medical and health sciences, Antisickling Agents, Antisickling Agents/therapeutic use, Humans, Hydroxyurea, 0303 health sciences, Polymorphism, Genetic, Nitric Oxide/therapeutic use, Poloxamer/therapeutic use, 3. Good health, Sulfasalazine, Butyrates, Phenotype, Butyrates/therapeutic use, Pharmacogenetics, Azacitidine

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/16981849
http://www.ncbi.nlm.nih.gov/pubmed/16981849
https://doi.org/10.2217/14622416.7.6.909
http://olympias.lib.uoi.gr/jspui/handle/123456789/24468

Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome

Autoren: Brachet, Cécile Azzi, Nadira Demulder, Anne et al.

Quelle: Bone Marrow Transplantation. 33:799-803

Schlagwörter: Male, Antisickling Agents -- therapeutic use, Transplantation Conditioning, Graft vs Host Disease, Anemia, Sickle Cell, 03 medical and health sciences, Hydroxyurea -- therapeutic use, 0302 clinical medicine, Antisickling Agents, Seizures, Humans, Hydroxyurea, Hematopoietic Stem Cell Transplantation -- adverse effects, Preschool, Child, Graft Survival, Sickle Cell -- drug therapy, Hematopoietic Stem Cell Transplantation, Anemia, Sciences bio-médicales et agricoles, Sickle Cell -- therapy, 3. Good health, Child, Preschool, Seizures -- etiology, Female, Graft vs Host Disease -- etiology

Dateibeschreibung: 1 full-text file(s): application/pdf

Zugangs-URL: https://www.nature.com/articles/1704443.pdf
https://pubmed.ncbi.nlm.nih.gov/14767501
https://core.ac.uk/display/8857345
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/57765/Details
https://www.nature.com/articles/1704443.pdf
https://www.nature.com/articles/1704443

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

Autoren: Ferster, Alina Tahriri, Parvine Vermylen, C et al.

Quelle: Blood. 97:3628-3632

Schlagwörter: Adult, Male, Antisickling Agents -- therapeutic use, Chest Pain, Adolescent, Arterial Occlusive Diseases, Anemia, Sickle Cell, Stroke -- etiology, Arterial Occlusive Diseases -- etiology, Arterial Occlusive Diseases -- prevention & control, 03 medical and health sciences, Hydroxyurea -- therapeutic use, 0302 clinical medicine, Antisickling Agents, Humans, Hydroxyurea, Registries, Preschool, Child, Aplastic -- prevention & control, Splenomegaly -- prevention & control, Chest Pain -- prevention & control, 2. Zero hunger, Sickle Cell -- drug therapy, Stroke -- prevention & control, Anemia, Aplastic, Anemia, Oxygen -- blood, Sciences bio-médicales et agricoles, Length of Stay, 3. Good health, Hospitalization, Oxygen, Stroke, Aplastic -- etiology, Child, Preschool, Splenomegaly -- etiology, Acute Disease, Splenomegaly, Sickle Cell -- complications, Female, Chest Pain -- etiology

Dateibeschreibung: No full-text files

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/11369660
https://www.ncbi.nlm.nih.gov/pubmed/11369660
https://www.sciencedirect.com/science/article/pii/S0006497120555845
https://biblio.ugent.be/publication/168826
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/60190/Details
https://pubmed.ncbi.nlm.nih.gov/11369660/
https://ashpublications.org/blood/article/97/11/3628/107474/Five-years-of-experience-with-hydroxyurea-in

Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment

Autoren: Makis, A. C. Hatzimichael, E. C. Kolios, G. et al.

Schlagwörter: Adult, Male, Antisickling Agents/*therapeutic use, Anemia, Sickle Cell/*blood/*drug therapy, Humans, Female, Endothelin-3/*blood, Hydroxyurea/*therapeutic use, Middle Aged, 3. Good health

Zugangs-URL: http://olympias.lib.uoi.gr/jspui/handle/123456789/23111

L'anémie falciforme et la malaria à plasmodium falciparum: une menace pour la survie des lambeaux

Autoren: Mariethoz, Sophie Pittet Cuenod, Brigitte Maud Loutan, Louis et al.

Schlagwörter: Hydroxyurea/therapeutic use, Research, Malaria, Falciparum/blood/complications, Pentoxifylline/therapeutic use, Surgical Flaps, Risk Factors, Leg Ulcer/etiology, Anemia, Sickle Cell/blood/complications/drug therapy, Vasodilator Agents/therapeutic use, Antisickling Agents/therapeutic use, Humans, Postoperative Complications/etiology, Child

Dateibeschreibung: application/pdf

Zugangs-URL: https://archive-ouverte.unige.ch/unige:74242
https://archive-ouverte.unige.ch/unige:72855

MRI abnormalities in infants with sickle cell anemia—indication for preemptive therapy?

Autoren: Ozsahin, Ayse Hulya

Quelle: Pediatric Blood & Cancer. 51:573-574

Schlagwörter: Clinical Trials as Topic, Hydroxyurea/therapeutic use, Brain, Infant, Anemia, Sickle Cell, Anemia, Sickle Cell/*complications, Stroke/etiology/*prevention & control, Magnetic Resonance Imaging, Stroke, 03 medical and health sciences, 0302 clinical medicine, Antisickling Agents, Antisickling Agents/therapeutic use, Humans, Hydroxyurea, Brain/*pathology

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/18623220
https://core.ac.uk/display/60773985
https://www.ncbi.nlm.nih.gov/pubmed/18623220
https://europepmc.org/abstract/MED/18623220
http://onlinelibrary.wiley.com/doi/10.1002/pbc.21704/abstract
https://archive-ouverte.unige.ch/unige:19203
https://archive-ouverte.unige.ch/unige:19203
https://doi.org/10.1002/pbc.21704

Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia

Autoren: Darbari, Deepika S. Nouraie, Mehdi Taylor, James G. et al.

Quelle: Pediatrics Faculty Publications

Schlagwörter: Anemia, Sickle Cell--complications, Sickle Cell--drug therapy, Antisickling Agents--therapeutic use, Hydroxyurea--therapeutic use, alpha-Thalassemia--complications, Pediatrics

Relation: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/1031; http://www.ncbi.nlm.nih.gov/pubmed?holding=dcgwulib_fft_ndi&dr=abstract&otool=dcgwulib&term=24330217

Verfügbarkeit: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/1031
http://www.ncbi.nlm.nih.gov/pubmed?holding=dcgwulib_fft_ndi&dr=abstract&otool=dcgwulib&term=24330217

Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice

Autoren: Almeida, Camila Bononi Scheiermann, Christoph Jang, Jung-Eun et al.

Quelle: ISSN: 0006-4971 ; Blood, vol. 120, no. 14 (2012) p. 2879-2888.

Schlagwörter: 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors/metabolism, Acute Disease, Anemia, Sickle Cell/chemically induced/drug therapy/metabolism, Animals, Antisickling Agents/therapeutic use, Cell Adhesion/drug effects, Cell Communication, Cyclic GMP/metabolism, Disease Models, Animal, Endothelium, Vascular/cytology/drug effects/metabolism, Erythrocytes/cytology/drug effects, Female, Humans, Hydroxyurea/therapeutic use, Leukocyte Rolling, Leukocytes/cytology/drug effects, Male, Mice, Inbred C57BL, Pyrazoles/pharmacology, Pyrimidines/pharmacology, Tumor Necrosis Factor-alpha/toxicity, Vascular Diseases/chemically induced/drug therapy/metabolism

Relation: info:eu-repo/semantics/altIdentifier/pmid/22833547; unige:113715

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:113715

L'anémie falciforme et la malaria a Plasmodium falciparum: une menace pour la survie des lambeaux?

Autoren: Mariethoz, Sophie Pittet Cuenod, Brigitte Maud Loutan, Louis et al.

Quelle: ISSN: 0294-1260 ; Annales de chirurgie plastique et esthétique, vol. 44, no. 1 (1999) p. 81-88.

Schlagwörter: info:eu-repo/classification/ddc/617, info:eu-repo/classification/ddc/618, Anemia, Sickle Cell/blood/complications/drug therapy, Antisickling Agents/therapeutic use, Child, Humans, Hydroxyurea/therapeutic use, Leg Ulcer/etiology, Malaria, Falciparum/blood/complications, Pentoxifylline/therapeutic use, Postoperative Complications/etiology, Research, Risk Factors, Surgical Flaps, Vasodilator Agents/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/10188298; unige:72855

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:72855

Hydroxyurea Use Among Medicaid Beneficiaries with Sickle Cell Disease in California and Georgia, 2006–2016

Weitere Verfasser: National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Sickle Cell Data Collection Program.

Schlagwörter: Anemia, Sickle Cell/therapy, Antisickling Agents/therapeutic use, Hydroxyurea/therapeutic use

Geographisches Schlagwort: California, Georgia

Dateibeschreibung: 2 unnumbered pages

Relation: https://stacks.cdc.gov/view/cdc/133048

Verfügbarkeit: https://stacks.cdc.gov/view/cdc/133048